NettetJosep Baselga i Torres, known in Spanish as José Baselga (3 July 1959 – 21 March 2024) was a Spanish medical oncologist and researcher focused on the development of novel molecular targeted agents, with a … Nettet11. sep. 2024 · One of America’s most prominent breast cancer doctors failed to disclose pharmaceutical industry ties worth millions of dollars in authoring dozens of articles in major journals, according to a report by the New York Times and ProPublica. José Baselga, physician-in-chief at Memorial Sloan Kettering Cancer Center in New York …
JOSE BASELGA Obituary (2024) - New York, NY - New York Times …
Nettet24. okt. 2024 · The case of José Baselga and his undisclosed payments of millions of dollars is generating much needed discussion on conflicts of interest and academic leadership. The lay press and The New York Times in particular have vilified industry-physician relationships and cast aspersions on all such endeavors with a focus on the … Nettet21. mar. 2024 · Después de que The New York Times difundiera esta información, Baselga se comprometió a corregir en 17 artículos sus informes de conflicto de intereses, publicados en revistas especializadas ... in addition besides 違い
JOSE BASELGA Obituary (2024) - New York, NY - New York Times …
Nettet19. sep. 2024 · By Chuck Dinerstein, MD, MBA — September 19, 2024. You know it is going to be a bad day when you are featured in the New York Times, well really, any … Nettet22. mar. 2024 · Though still highly regarded by many, Baselga's legacy isn't without controversy. In 2024, The New York Times and ProPublica reported that Baselga, whose name appears on hundreds of peer-reviewed articles and publications, had failed to disclose millions of dollars in payments from pharmaceutical and healthcare companies. Nettet22. des. 2024 · Dr. José Baselga resigned as chief medical officer after payments he received from for-profit health care companies came to light in 2024. ... This story was … in addition besides moreover